Tivic Health Systems Net Income 2020-2024 | TIVC
Tivic Health Systems net income from 2020 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| Tivic Health Systems Annual Net Income (Millions of US $) |
|
|---|---|
| 2023 | $-8 |
| 2022 | $-10 |
| 2021 | $-8 |
| 2020 | $-4 |
| 2019 | $-4 |
| Tivic Health Systems Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2024-06-30 | $-1 |
| 2024-03-31 | $-1 |
| 2023-12-31 | $-2 |
| 2023-09-30 | $-2 |
| 2023-06-30 | $-2 |
| 2023-03-31 | $-2 |
| 2022-12-31 | $-2 |
| 2022-09-30 | $-3 |
| 2022-06-30 | $-3 |
| 2022-03-31 | $-2 |
| 2021-12-31 | $-4 |
| 2021-09-30 | $-2 |
| 2021-06-30 | $-1 |
| 2021-03-31 | $-1 |
| 2020-12-31 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.002B | $0.001B |
| Tivic Health Systems Inc. is a commercial-phase healthtech company advancing bioelectronic medicine to deliver non-invasive solutions which treat disease, increase wellness and improve lives. Its first product includes ClearUP(R). Tivic Health Systems Inc. is based in MENLO PARK, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $42.008B | 22.60 |
| Tempus AI (TEM) | United States | $8.309B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $6.038B | 1124.89 |
| Hims & Hers Health (HIMS) | United States | $3.817B | 222.13 |
| Axonics (AXNX) | United States | $3.550B | 0.00 |
| 10x Genomics (TXG) | United States | $2.732B | 0.00 |
| Enovis (ENOV) | United States | $2.437B | 17.66 |
| Azenta (AZTA) | United States | $2.415B | 137.17 |
| IRhythm Technologies (IRTC) | United States | $2.276B | 0.00 |
| Privia Health (PRVA) | United States | $2.162B | 150.67 |
| Omnicell (OMCL) | United States | $1.979B | 65.18 |
| Clover Health Investments (CLOV) | United States | $1.403B | 0.00 |
| Schrodinger (SDGR) | United States | $1.364B | 0.00 |
| Phreesia (PHR) | United States | $1.313B | 0.00 |
| Standard BioTools (LAB) | United States | $0.713B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.641B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.520B | 441.00 |
| Health Catalyst (HCAT) | United States | $0.503B | 0.00 |
| Talkspace (TALK) | United States | $0.341B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.336B | 0.00 |
| Pulmonx (LUNG) | United States | $0.325B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.244B | 0.00 |
| TruBridge (TBRG) | United States | $0.179B | 13.12 |
| American Well (AMWL) | United States | $0.142B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.140B | 0.00 |
| Augmedix (AUGX) | United States | $0.116B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.099B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| HeartBeam (BEAT) | United States | $0.061B | 0.00 |
| Zepp Health (ZEPP) | China | $0.060B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.052B | 0.00 |
| CareCloud (CCLD) | United States | $0.042B | 0.00 |
| Movano (MOVE) | United States | $0.037B | 0.00 |
| Outset Medical (OM) | United States | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.022B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.022B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.018B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.015B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Syra Health (SYRA) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |